Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1996 Nov;51(11):1093–1099. doi: 10.1136/thx.51.11.1093

Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.

J E Garrett 1, S F Lanes 1, J Kolbe 1, H H Rea 1
PMCID: PMC1090519  PMID: 8958891

Abstract

BACKGROUND: A study was undertaken to test the hypothesis that a particular inhaled beta agonist, fenoterol, increases the incidence of severe life threatening asthma. METHODS: A retrospective cohort was assembled comprising 655 patients with asthma aged 15-55 years who attended a single Auckland hospital for acute asthma between 1 January 1986 and 31 December 1987 (the "index event"). Patients were followed for the occurrence of death from asthma or admission to the intensive care unit for asthma, until death or 31 May 1989. Data on asthma medications and asthma severity were obtained from forms used specifically for managing patients with acute asthma in the emergency department and maintained as part of the hospital record and/or from the hospital record (when patients were admitted). RESULTS: Following the index event 90 admissions to the intensive care unit (ICU) and 15 asthma deaths were identified. Before adjusting for asthma severity, patients using inhaled fenoterol had a greater incidence of severe life threatening asthma than patients using inhaled salbutamol (RR = 2.1, 95% CI 1.4 to 3.1). After controlling for two markers of severe asthma used in previous studies-a hospital admission in the previous year and prescribed oral corticosteroids-the relative risk estimate declined to 1.5 (95% CI 1.0 to 2.3). After controlling further for the number of hospital admissions during the study period, continuous oral corticosteroid use rather than short courses of treatment, severity of the previous attack requiring a hospital visit, and race, fenoterol was not associated with severe life threatening asthma at the time of attendance for a previous hospital visit (RR = 1.0, 95% CI 0.6 to 1.7). CONCLUSION: Fenoterol is used more often by patients with severe asthma and, after adjusting for differences in baseline risk, it does not increase the risk of severe life threatening asthma.

Full text

PDF
1093

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brenner H. Bias due to non-differential misclassification of polytomous confounders. J Clin Epidemiol. 1993 Jan;46(1):57–63. doi: 10.1016/0895-4356(93)90009-p. [DOI] [PubMed] [Google Scholar]
  2. Burgess C., Pearce N., Thiruchelvam R., Wilkinson R., Linaker C., Woodman K., Crane J., Beasley R. Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J. 1994 Mar;7(3):498–503. doi: 10.1183/09031936.94.07030498. [DOI] [PubMed] [Google Scholar]
  3. Crane J., Pearce N., Flatt A., Burgess C., Jackson R., Kwong T., Ball M., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet. 1989 Apr 29;1(8644):917–922. doi: 10.1016/s0140-6736(89)92505-1. [DOI] [PubMed] [Google Scholar]
  4. Garrett J. E., Mulder J., Wong-Toi H. Characteristics of asthmatics using an urban accident and emergency department. N Z Med J. 1988 Jun 8;101(847 Pt 1):359–361. [PubMed] [Google Scholar]
  5. Garrett J. E., Mulder J., Wong-Toi H. Reasons for racial differences in A & E attendance rates for asthma. N Z Med J. 1989 Mar 22;102(864):121–124. [PubMed] [Google Scholar]
  6. Garrett J., Lanes S. F. Baseline risk for asthma death. N Z Med J. 1992 Aug 12;105(939):319–319. [PubMed] [Google Scholar]
  7. Grainger J., Woodman K., Pearce N., Crane J., Burgess C., Keane A., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax. 1991 Feb;46(2):105–111. doi: 10.1136/thx.46.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989 Mar;79(3):340–349. doi: 10.2105/ajph.79.3.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lanes S. F., Poole C., Walker A. M. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax. 1992 Jul;47(7):574–575. doi: 10.1136/thx.47.7.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lanes S. F., Poole C., Walker A. M. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax. 1992 Jul;47(7):574–575. doi: 10.1136/thx.47.7.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pearce N., Grainger J., Atkinson M., Crane J., Burgess C., Culling C., Windom H., Beasley R. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax. 1990 Mar;45(3):170–175. doi: 10.1136/thx.45.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rea H. H., Scragg R., Jackson R., Beaglehole R., Fenwick J., Sutherland D. C. A case-control study of deaths from asthma. Thorax. 1986 Nov;41(11):833–839. doi: 10.1136/thx.41.11.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Richards G. N., Kolbe J., Fenwick J., Rea H. H. Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths. Thorax. 1993 Nov;48(11):1105–1109. doi: 10.1136/thx.48.11.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
  15. Suissa S., Ernst P., Boivin J. F., Horwitz R. I., Habbick B., Cockroft D., Blais L., McNutt M., Buist A. S., Spitzer W. O. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):604–610. doi: 10.1164/ajrccm.149.3.8118625. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES